Clinical trial
Prophylactic Treatment of Episodic Cluster Headache
NCT00184587 · Norwegian University of Science and Technology, Other · Completed
Key facts
| NCT number | NCT00184587 |
|---|---|
| Title | Prophylactic Treatment of Episodic Cluster Headache |
| Official title | Prophylactic Treatment of Episodic Cluster Headache With an Angiotensin II Receptor Blocker (Candesartan Cilexetil); a Randomized, Placebo Controlled Parallel Study |
| Lead sponsor | Norwegian University of Science and Technology, Other |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cluster Headache |
| Intervention type | Drug |
| Interventions | candesartan cilexetil, placebo |
| Enrollment | 40 |
| Start date | Mar 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 23, 2013 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: